CellaVision AB - Asset Resilience Ratio

Latest as of December 2022: -0.58%

CellaVision AB (CEVI) has an Asset Resilience Ratio of -0.58% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr-5.15 Million

≈ $-554.44K USD Cash + Short-term Investments

Total Assets

Skr891.75 Million

≈ $95.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2022)

This chart shows how CellaVision AB's Asset Resilience Ratio has changed over time. Check CellaVision AB (CEVI) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down CellaVision AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is CellaVision AB worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr-5.15 Million	-0.58%
Total Liquid Assets	Skr-5.15 Million	-0.58%

Asset Resilience Insights

Limited Liquidity: CellaVision AB maintains only -0.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CellaVision AB Industry Peers by Asset Resilience Ratio

Compare CellaVision AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for CellaVision AB (2012–2022)

The table below shows the annual Asset Resilience Ratio data for CellaVision AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.58%	Skr-5.15 Million ≈ $-554.44K	Skr891.75 Million ≈ $95.97 Million	+2.06pp
2021-12-31	-2.64%	Skr-21.79 Million ≈ $-2.34 Million	Skr825.21 Million ≈ $88.81 Million	-0.06pp
2020-12-31	-2.58%	Skr-17.25 Million ≈ $-1.86 Million	Skr668.02 Million ≈ $71.89 Million	+0.21pp
2019-12-31	-2.79%	Skr-17.93 Million ≈ $-1.93 Million	Skr641.71 Million ≈ $69.06 Million	-16.83pp
2013-12-31	14.03%	Skr26.47 Million ≈ $2.85 Million	Skr188.57 Million ≈ $20.29 Million	+13.86pp
2012-12-31	0.18%	Skr318.00K ≈ $34.22K	Skr178.56 Million ≈ $19.22 Million	--

pp = percentage points

About CellaVision AB

ST:CEVI Sweden Medical Devices

Market Cap

$379.89 Million

Skr3.53 Billion SEK

Market Cap Rank

#13583 Global

#218 in Sweden

Share Price

Skr148.00

Change (1 day)

+0.54%

52-Week Range

Skr118.40 - Skr188.40

All Time High

Skr478.48